BASF AS

ACCELON

Excipients sold as an ingredient of dietary and nutritional supplements; excipients sold as an ingredient of dietary and nutritional supplements for endurance sports; excipients sold as an ingredient of medicinal oils; excipients sold as an ingredient of dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; excipients sold as an ingredient of biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; excipients sold as an ingredient of dietetic substances, namely, omega-3 concentrate adapted for medical use; excipients sold as an ingredient of nutritional supplements adapted for medical use; excipients sold as an ingredient of nutritional supplements; excipients sold as an ingredient of food supplements for medical purposes;Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplements;

ACCELOR

Dietary and nutritional supplements; dietary and nutritional supplements for endurance sports; medicinal oils; dietetic foods, namely, omega 3 capsules, tablets, gels, chewables, smoothies, enteral feed formulas, liquid nutritive preparations for oral or tube feeding and nutritional bars with omega-3 formulation, adapted for medical purposes; biological preparations for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; dietetic beverages adapted for nutritional support for the treatment or prevention of cancer, cachexia, concussion, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, hypertriglyceridemia (HTG), metabolic syndrome, sarcopenia, chronic inflammatory diseases and diabetes; dietetic substances, namely, omega-3 concentrate adapted for medical use; nutritional supplements adapted for medical use; nutritional supplements; food supplements for medical purposes;Excipients for use in the manufacture of pharmaceutical preparations and/or dietary supplements;

ALDRABIX

Pharmaceutical products in the form of unsaturated fatty acids for the prevention or treatment of metabolic diseases;

BRISMARANT

Pharmaceutical products in the form of unsaturated fatty acids for the prevention or treatment of metabolic diseases;The wording BRISMARANT has no meaning in a foreign language.;

HEPACOR

Dietetic foods, namely, gelatin capsules containing Omega-3 fish oil concentrate, for medicinal purposes;

HEPAXA

Dietetic foods, namely, gelatin capsules containing omega-3 fish oil concentrate, for medicinal purposes;

PRONOVA BIOPHARMA

The mark consists of the words Pronova Biopharma in a stylized format and a circular globe above the second o in Pronova.;Pharmaceutical preparations for use in the treatment of metabolic, inflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolic, inflammatory and cardiovascular diseases; substances with marine origin, namely, Omega 3 lipids for pharmaceutical purposes used in the treatment of metabolic, inflammatory and cardiovascular diseases;PRONOVA BIOPHARMACEUTICAL;Color is not claimed as a feature of the mark.;BIOPHARMA;